12% Of U.S. Adults Have Taken GLP-1 Medications

Approximately 12.5% of American adults (more than 15 million people, or about 1 in 8 adults) said they have taken a glucagon-like peptide-1 (GLP-1) agonist medication, such as Ozempic, at some point in their lives. Among those adults who have reported taking a GLP-1 agonist in their lifetime, 43% have been told by a physician that they have diabetes, 25% have been told they have heart disease, and 22% have been told in the past five years they were overweight or obese.

A GLP-1 agonist is a 30- or 31-amino-acid-long peptide . . .